Healthcare Providers and Services
Company Overview of El Camino Hospital
El Camino Hospital, a not-for-profit organization, operates hospitals serving communities in the South San Francisco Bay Area. Its programs and services include bariatric surgery, behavioral health, Chinese health initiative, clinical trial, community and corporate health, CyberKnife, da Vinci surgical system, dialysis, eating disorders, emergency, and endoscopy. The company also provides imaging, interventional pulmonology, inpatient rehabilitation, joint replacement, laboratory, maternal-child health, men's health program, orthopedics, pediatrics, rehabilitation, robotic surgery, senior, stroke, support, surgical, urology, vein, and weight loss surgery services. In addition, it offers geno...
2500 Grant Road
Mountain View, CA 94040
Founded in 1958
Key Executives for El Camino Hospital
Chief Executive Officer and President
Vice President of Professional Corporate and Community Health Services and Chief Executive Officer of Concern
Compensation as of Fiscal Year 2013.
El Camino Hospital Key Developments
Strand Life Sciences Private Limited Collaborates with El Camino Hospital to Set Up Strand Center for Genomics and Personalized Medicine
Dec 5 13
Strand Life Sciences Private Limited is collaborating with El Camino Hospital to locate a Strand Center for Genomics and Personalized Medicine at the Genomic Medicine Institute of the El Camino Hospital to accelerate the adoption of next generation sequencing based research panels and counseling services by the physicians at the Hospital and its partner clinics.
El Camino Hospital Enrolls Second Patient in Global Clinical Trial Evaluating the Medtronic CoreValve(R) System in Intermediate Risk Patients with Aortic Valve Disease
Sep 11 13
El Camino Hospital, in partnership with the Taft Center for Clinical Research and the Fogarty Clinical Research Institute, both a part of the Fogarty Institute for Innovation, announced that it has enrolled its second patient in a global clinical trial comparing the Medtronic CoreValve(R) System with surgical aortic valve replacement in patients with severe aortic stenosis who are at intermediate risk for open-heart surgery. The Medtronic CoreValve Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial is the large global, randomized, controlled trial to evaluate minimally-invasive transcatheter aortic valve implantation in less-sick patients who are typically treated with open-heart surgical aortic valve replacement (SAVR). The trial will evaluate whether the CoreValve System is non-inferior to surgical valve replacement based on the composite primary endpoint of all-cause mortality and disabling stroke at 24 months. Aortic stenosis occurs when the heart's aortic valve is narrowed, restricting blood flow from the heart to the body. The condition primarily affects older people and typically develops in individuals between the ages of 50 and 70, and research shows that, if left untreated, as many as 50% of aortic stenosis patients with severe symptoms may die within one year. Currently, the standard treatment for severe aortic stenosis, which affects approximately 300,000 people worldwide, is open-heart valve replacement surgery. However, due to possible health complications, one-third of these patients are considered ineligible for the procedure.
El Camino Hospital and Professional Resource for Nurses Announce Tentative Agreement on Three-Year Contract
Mar 18 13
El Camino Hospital announced that they have reached a tentative agreement on a three year contract for the hospital's registered nurses. tentative agreement is set to be ratified by PRN members on March 28 and the hospital Board of Directors will consider endorsing the agreement at its next meeting on April 10, 2013.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|